The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Nuclear receptors: integration of multiple signalling pathways through phosphorylation
Abstract
Nuclear receptors (NRs) orchestrate the transcription of specific gene networks in response to binding of their cognate ligand. They also act as mediators in a variety of signalling pathways through integrating diverse phosphorylation events. NR phosphorylation concerns all three major domains, the N-terminal activation function (AF-1), the ligand-binding and the DNA binding domains. Often, phosphorylation of NRs by kinases that are associated with general transcription factors (e.g. cdk7 within TFIIH), or activated in response to a variety of signals (MAPKs, Akt, PKA, PKC), facilitates the recruitment of coactivators or of components of the transcription machinery and, therefore, cooperates with the ligand to enhance transcription activation. But phosphorylation can also contribute to the termination of the ligand response through inducing DNA dissociation or NR degradation or through decreasing ligand affinity. These different modes of regulation reveal an unexpected complexity of the dynamics of NR-mediated transcription. In addition, deregulation of NR phosphorylation may impact their action in certain diseases or cancers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For several years, RARs and RXRs have been known to be phosphoproteins ( 129 ).”
From Vitamin A and retinoid signaling: genomic and nongenomic effects (2013) · cites this paper as [129]
Citations
Cites
2 retracted
Endoh, H., Maruyama, K., Masuhiro, Y., Kobayashi, Y., Goto, M., Tai, H., Yanagisawa, J., METZGER, D., Hashimoto, S., & Kato, S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.01458-13 · Cited by 363
RetractedWatanabe, M., Yanagisawa, J., Kitagawa, H., Takeyama, K., Ogawa, S., Arao, Y., Suzawa, M., Kobayashi, Y., Yano, T., Yoshikawa, H., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1341 · Cited by 267
RetractedThe nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Mammalian MAP kinase signalling cascades
Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,118
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
Pearson, G. W., Robinson, F. L., Gibson, T. B., Xu, B.-E., Karandikar, M. S., Berman, K. S., & Cobb, M. H. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0428 · Cited by 4,111
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
Molecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,288
A decade of molecular biology of retinoic acid receptors
Chambon, P. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.9.8801176 · Cited by 2,889
Research works printed but not linked: 14
- Glass, 1994, Endocr. Rev., 15, 391
- Giguere, 1999, Endocr. Rev., 20, 689
- Pearson, 2001, Endocr. Rev., 22, 153
- Arnold, 1995, Mol. Endocrinol., 9, 24
- Migliaccio, 1993, Oncogene, 8, 2183
- Huggenvick, 1994, Mol. Endocrinol., 7, 543
- Rochette-Egly, 1995, Mol. Endocrinol., 9, 860
- Rochette-Egly, 2001, Histol. Histopathol., 16, 909
- Endoh, 1999, Mol. Cell Biol., 19, 5363, 10.1128/MCB.19.8.5363 · DOI
- Rochette-Egly, 2000, Mol. Endocrinol., 14, 1398
- Matsushima-Nishiwaki, 2001, Cancer Res., 61, 7675
- Wen, 2000, Cancer Res., 60, 6841
- Zhang, 1995, Mol. Endocrinol., 9, 1029
- Joel, 1995, Mol. Endocrinol., 9, 1041
Cited by
Sorted by citations
Items 201–292 of 292
Sridhara, S. (2011) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2011.11.001 · Cited by 10
Pin1 and Nuclear Receptors: A New Language?
Montagna, R. L., Caligiuri, I., Giordano, A., & Rizzolio, F. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24316 · Cited by 10
Inhibition of the Androgen Receptor Activity by Coprinus comatus Substances
Dotan, N., Wasser, S. P., & Mahajna, J. A. (2011) · Nutrition and Cancer · doi:10.1080/01635581.2011.607542 · Cited by 10
Molecular Cross-Talk Between Nuclear Receptors and Nuclear Factor-κB
Beck, I. M. E., Haegeman, G., & Bosscher, K. D. (2010) · Springer eBooks · doi:10.1007/978-90-481-9531-2_10 · Cited by 9
PROTAC technology for prostate cancer treatment
Wang, Z., Zhang, D., Inuzuka, H., & Wei, W. (2025) · Acta Materia Medica · doi:10.15212/amm-2024-0075 · Cited by 9
MSK1 and Nuclear Receptors Signaling
Piskunov, A., & Rochette‐Egly, C. (2013) · Cited by 9
Self-citationZhang, D., Song, Y., Kong, P., Xu, X., Gao, Y., Dou, Y., Weng, L., Wang, X., Lin, Y.-L., Zhang, F., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04360-w · Cited by 9
Allosteric Regulation in the Ligand Binding Domain of Retinoic Acid Receptorγ
Chebaro, Y., Sirigu, S., Amal, I., Lutzing, R., Stote, R. H., Rochette-Egly, C., Rochel, N., & Dejaegere, A. (2017) · PLOS ONE · doi:10.1371/journal.pone.0171043 · Cited by 8
Self-citationType II nuclear receptors with potential role in Alzheimer disease
Muñoz-Cabrera, J., Adrián, S.-H., & Arboleda, G. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100940 · Cited by 9
Low-dose ethanol suppresses 17β-estradiol activity in GH4C1 pituitary tumor cells
Wang, G., Chen, D., Luo, H., Liu, J., Ji, X., Fan, J., & Cui, S. (2009) · Cell Biology and Toxicology · doi:10.1007/s10565-009-9129-7 · Cited by 7
Wartalski, K., Knet, M., Hoja-Łukowicz, D., Tabarowski, Z., & Duda, M. (2016) · Acta Histochemica · doi:10.1016/j.acthis.2016.03.008 · Cited by 7
Inoue, T., Kobayashi, T., Terada, N., Shimizu, Y., Kamoto, T., Ogawa, O., & Nakamura, E. (2007) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2.5.689 · Cited by 9
Development of drugs against hormone‐refractory prostate cancer
Kageyama, Y. (2008) · Drug Development Research · doi:10.1002/ddr.20274 · Cited by 6
Reyes-Quiróz, M. E., Álba, G., Santa‐María, C., Coronilla, J. S., Geniz, I., Jiménez, J., Ramírez, R., Martín‐Nieto, J., Pintado, E., & Sobrino, F. (2013) · FEBS Journal · doi:10.1111/febs.12662 · Cited by 6
High Throughput Analysis of Nuclear Receptor–Cofactor Interactions
Goodson, M. L., Farboud, B., & Privalsky, M. L. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-575-0_9 · Cited by 6
Stefanini, M. (2006) · Springer eBooks · doi:10.1007/0-387-36802-7_3 · Cited by 7
Horestani, M. H., & Baniahmad, A. (2025) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10302-1 · Cited by 5
Nguyen, H. D., Phan, T. T. P., Carraz, M., & Brunsveld, L. (2012) · Molecular BioSystems · doi:10.1039/c2mb25257k · Cited by 5
Modi, P. K., Faiena, I., & Kim, I. Y. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800077-9.00003-7 · Cited by 5
Casali, C. I., Weber, K., Faggionato, D. M., Gómez, E. M., & Tome, M. C. F. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.06.002 · Cited by 5
Multifunnel Energy Landscapes for Phosphorylated Translation Repressor 4E-BP2 and Its Mutants
Kang, W., Jiang, F., Wu, Y., & Wales, D. J. (2019) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.9b01042 · Cited by 5
Figlewicz, D. P., Jay, J. L., West, C. H., Zavosh, A., Hampe, C. S., Radtke, J. R., Raskind, M. A., & Peskind, E. R. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00340.2017 · Cited by 5
Expression, purification and characterization of methyl DNA binding protein from Bombyx mori
Uno, T., Nomura, Y., Nakamura, M., Nakao, A., Tajima, S., Kanamaru, K., Yamagata, H., & Iwanaga, Y. (2005) · Journal of Insect Science · doi:10.1673/031.005.0801 · Cited by 5
Role of HNF4α in the superinduction of the IL-1β-activated iNOS gene by oxidative stress
Gonzalez, F. J. (2006) · Biochemical Journal · doi:10.1042/bj20060005 · Cited by 5
The Nuclear Receptor Superfamily and Drug Discovery
Moore, J. T., Collins, J. L., & Pearce, K. H. (2007) · Chemical biology · doi:10.1002/9783527619375.ch15c · Cited by 5
The role of RARG in solid tumor progression and therapeutic potential
Guo, S., Han, H., Ding, B., Zhang, W., & Qin, L. (2026) · Discover Oncology · doi:10.1007/s12672-026-04706-w · Cited by 4
Martinez-Zapien, D., Delsuc, M., Travé, G., Lutzing, R., Rochette‐Egly, C., & Kieffer, B. (2013) · Protein Expression and Purification · doi:10.1016/j.pep.2013.12.001 · Cited by 4
Self-citationVitamin A Metabolism in the Fetus and Neonate
Ross, A. C., Tan, L., & Owusu, S. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-35214-7.00031-7 · Cited by 4
Jeon, M. J., Yang, W., Seo, H.-S., Wang, E. S., & Shin, I. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.07.011 · Cited by 4
Prognostic and Therapeutic Potential of Nuclear Receptors in Head and Neck Squamous Cell Carcinomas
Knauer, S. K. (2009) · Journal of Oncology · doi:10.1155/2009/349205 · Cited by 4
Dudkowska, M., Bajer, S., Jaworski, T., Zielińska, J., Manteuffel-Cymborowska, M., & Grzelakowska-Sztabert, B. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.12.015 · Cited by 3
Sakai, H., Shimizu, M., & Moriwaki, H. (2014) · Diseases · doi:10.3390/diseases2030226 · Cited by 3
Taneja, R. (2005) · Science s STKE · doi:10.1126/stke.2862005tr17 · Cited by 3
Protein Posttranslational Modification: A Potential Target in Pharmaceutical Development
Huq, M. D. M., & Wei, L. (2010) · Pharmaceutical Sciences Encyclopedia · doi:10.1002/9780470571224.pse302 · Cited by 3
Qin, L., Wen, F., Guo, S., Zhang, W., Cai, W., Ma, R., Liu, C., Ren, W., Ye, H., & Jiao, Z. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112552 · Cited by 2
Regulation of Bone Cell Function by Estrogens
Komm, B. S., Cheskis, B. J., & Bodine, P. V. N. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375098-3.50015-9 · Cited by 2
Renato, P., Correa, A. V., Nathanson, M. H., Wolkoff, A. W., Novikoff, P. M., Thevananther, S., Karpen, S. J., Elferink, R. P. J. O., Püschel, G. P., & Stieger, B. (2007) · Wiley eBooks · doi:10.1002/9780470691861.ch2b · Cited by 3
Estrogen receptors and anti-estrogen therapies.
Buluwela, L., Constantinidou, D., Pike, J., & Ali, S. (2004) · Cancer treatment and research · doi:10.1007/1-4020-7847-1_13 · Cited by 2
The Role of Cyclic AMP in Regulating the Androgen Receptor
Sadar, M. D. (2009) · Springer eBooks · doi:10.1007/978-0-387-69179-4_21 · Cited by 1
Novel Approaches to Androgen Receptor Blockade
Mellinghoff, I. K. (2006) · Translational medicine series · doi:10.3109/9781420019858.010 · Cited by 1
Endocrine Active Compounds Actions during Neonatal Period: Effect on the Ovary
Słomczyńska, M., Grzesiak, M., & Knapczyk‐Stwora, K. (2018) · InTech eBooks · doi:10.5772/intechopen.69220 · Cited by 1
Chemical and Drug Receptor Interactions
Konsoula, Z. (2010) · CRC Press eBooks · doi:10.3109/9781420092264-12 · Cited by 1
The Role of Androgens in Ovarian Follicular Development: From Fertility to Ovarian Cancer
Duda, M., Wartalski, K., Tabarowski, Z., & Gorczyca, G. (2017) · InTech eBooks · doi:10.5772/intechopen.68881 · Cited by 1
Kramer, I. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394803-8.00008-5 · Cited by 1
Control of Gene Expression by Nuclear Retinoic Acid Receptors
Carrier, M., & Rochette‐Egly, C. (2015) · doi:10.1002/9781118628003.ch5 · Cited by 1
Self-citationProstate Cancer: Role of Vav3 Overexpression in Development and Progression
Lu, S. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8442-3_31 · Cited by 1
Androgen Receptor Coregulators and Their Role in Prostate Cancer
Wafa, L. A., Snoek, R., & Rennie, P. S. (2009) · Springer eBooks · doi:10.1007/978-0-387-69179-4_15 · Cited by 1
Bolander, F. F. (2004) · Elsevier eBooks · doi:10.1016/b978-012111232-5/50006-3 · Cited by 1
CHAPTER 14 – Regulation of Bone Cell Function by Estrogens
Komm, B., Cheskis, B., & Bodine, P. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50016-1
Etude de DAX-1 et de sa perte de fonction dans l'hypoplasie congénitale des glandes surrénales
Lehmann, S. (2005) · OpenGrey (Institut de l'Information Scientifique et Technique)
Valadares, N. F. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.76.2008.tde-18122008-154730
Transcriptional regulation by the orphan nuclear receptor ERRgamma
Hirvonen, J. (2008) · Työväentutkimus Vuosikirja
Studies on the function of the NGFIC subfamily of nuclear receptors in adipose tissue.
Wakes, N. C. (2006) · UCL Discovery (University College London)
Regulation of Estrogen Receptor alpha Ubiquitination and Proteasome-mediated Receptor Degradation
Berry, N. B. (2008) · IUScholarWorks (Indiana University)
Molecular Dynamic Studies of Nuclear Receptors Ligand Binding Domain
Burendahl, S. (2009) · Figshare
Signalling Pathways and Gene Expression Profiles in Prostate Cancer
Hatziieremia, S., McCall, P., & Edwards, J. (2011) · InTech eBooks · doi:10.5772/26971
Bu, P. (2009) · KU ScholarWorks (The University of Kansas)
Tait, T. (2015) · SUNScholar (Stellenbosch University)
Nuclear receptor and cofactor expression in female reproductive tissues
Vienonen, A. (2004) · Tampere University Institutional Repository (Tampere University)
MOLECULAR DETERMINANTS OF ANDROGEN ACTION
Santti, H. (2004) · Työväentutkimus Vuosikirja
Tavakoli, I. (2013) · cIRcle (University of British Columbia) · doi:10.14288/1.0072850
Newell-Price, J. D. C., BERTAGNA, X. Y., Grossman, A. B., & Nieman, L. K. (2006)
Aldhamen, Y. A. (2007) · OhioLink ETD Center (Ohio Library and Information Network)
Cras, A., Guidez, F., & Chomienne, C. (2010) · Springer eBooks · doi:10.1007/978-90-481-3303-1_9
The Role of EGFR, HER 2-4, Heregulin and Downstream Signalling in Prostate Adenocarcinoma
Grimsley, S. J. S. (2008) · Enlighten: Theses (The University of Glasgow)
AlSudais, H. (2015) · uO Research (University of Ottawa) · doi:10.20381/ruor-4024
Mammalian Mat1 subunit of Transcription Factor IIH in gene-specific and general transcription
Helenius, K. (2011) · Työväentutkimus Vuosikirja
Characterizing the Pregnane X Receptor’s Interactions and Biophysical Properties
Carnahan, V. E. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/346x-vf17
Chemical– and Drug–Receptor Interactions
Konsoula, Z. (2019) · CRC Press eBooks · doi:10.1201/9780429154829-11
A brief overview of androgen receptor: Its structure, functions and role in health and disease
Nikhil, K., Sharan, S., & Roy, P. (2013) · Journal of Endocrinology & Reproduction · doi:10.18519/jer/2013/v17/75783
Hitchcock, D. J. (2014) · NORA - Norwegian Open Research Archives
Androgen receptor-mediated growth suppression and apoptosis of human prostate epithelial cells
Chen, C. (2016) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
14-3-3 sigma interacts with liver X receptor beta
Jackson, E. A. (2010) · Louisiana State University · doi:10.31390/gradschool_theses.4251
The Effect of DHT Treatment on Changes in Amino Acid Transport Occurring in Aged Muscle
Wendowski, O. (2018) · UEA Digital Repository (University of East Anglia)
Maltais, A. (2006) · Corpus Université Laval (Université Laval)
Semenenya, I. N., Shlyahtun, A. H., & Радута, Е. Ф. (2019) · Proceedings of the National Academy of Sciences of Belarus Medical series · doi:10.29235/1814-6023-2019-16-2-244-256
Gomperts, B. D., Kramer, I. M., & Tatham, P. E. R. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369441-6.00010-6
RXR – centralny regulator wielu ścieżek sygnałowych w organizmie
Sołtys, K., Leszczyński, B., & Ożyhar, A. (2021) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.2478/ahem-2021-0005
Regulation of the Pregnane X Receptor Signaling Pathway
Lichti-Kaiser, K. (2009) · KU ScholarWorks (University of Kansas)
Liu, Y., Mo, J. Q., Hu, Q., Boivin, G. P., Levin, L. S., Lu, S., Yang, D., & Dong, Z. (2023) · doi:10.1158/0008-5472.c.6498122
Liu, Y., Mo, J. Q., Hu, Q., Boivin, G. P., Levin, L. S., Lu, S., Yang, D., & Dong, Z. (2023) · doi:10.1158/0008-5472.c.6498122.v1
Evolution of Steroid Signaling in Metazoans
Markov, G. V. (2011) · theses.fr (ABES) · doi:10.70675/816a1939zc7e3z4c7azb90fzf9d9a08011af
Role of PGC-1β and TIF2 co-regulators in mouse skeletal muscle function
Ramamoorthy, T. G. (2013) · theses.fr (ABES) · doi:10.70675/e05002c4z4806z4363z90b1z0e406b6c0e4c
Zeng, C., Wenhui, Y., Kang, Y., Liu, W., Chen, Z., Xiao, Z., Liu, Z., Zhang, W., Li, Q., Zeng, Y., et al. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.10.020
Metadata
- Authors
- Rochette-Egly, C.
- Venue
- Cellular Signalling
- Publisher
- Elsevier BV
- Published
- 2003-04
- Volume
- 15
- Issue
- 4
- Pages
- 355-366
- ISSN
- 0898-6568 (ISSN-L)
- OpenAlex
- W2056128228
- Cited by
- 291
- References
- 136
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 4 · 2021: 7 · 2020: 2 · 2019: 7 · 2018: 5 · 2017: 8 · 2016: 7 · 2015: 12 · 2014: 15 · 2013: 21 · 2012: 10
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cellular Signalling (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- nuclear receptors, phosphorylation, transcriptional regulation, transcriptional coactivator, ligand-binding domain, DNA-binding domain, mitogen-activated protein kinase, Akt, protein kinase A, protein kinase C, CDK7, TFIIH, transcription termination, ligand dissociation, cancer
- MeSH terms
- Animals, Cell Nucleus, DNA-Binding Proteins, Hormones, Humans, Neoplasms, Phosphorylation, Protein Binding, RNA, Messenger, Transcription, Genetic, Signal Transduction, Down-Regulation, Up-Regulation, Protein Serine-Threonine Kinases, Receptors, Cytoplasmic and Nuclear
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review